Last reviewed · How we verify

Vaccine manufactured at commercialized scale — Competitive Intelligence Brief

Vaccine manufactured at commercialized scale (Vaccine manufactured at commercialized scale) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: vaccine. Area: Immunology.

phase 3 vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Vaccine manufactured at commercialized scale (Vaccine manufactured at commercialized scale) — Sinovac (Dalian) Vaccine Technology Co., Ltd.. This vaccine works by stimulating the body's immune system to produce a protective response against the SARS-CoV-2 virus.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Vaccine manufactured at commercialized scale TARGET Vaccine manufactured at commercialized scale Sinovac (Dalian) Vaccine Technology Co., Ltd. phase 3 vaccine
Comirnaty BNT162b2 (tozinameran) Pfizer Inc. marketed vaccine SARS-CoV-2 virus 2021-08-23
Prevnar 20 pneumococcal 20-valent conjugate vaccine (PCV20) Pfizer Inc. marketed Pneumococcal conjugate vaccine Streptococcus pneumoniae capsular polysaccharides (20 serotypes) 2021-06-08
BNT162b5 Bivalent (WT/OMI BA.2) bnt162b5-bivalent-wt-omi-ba-2 Pfizer marketed mRNA vaccine SARS-CoV-2 spike protein
MVC-COV1901(6 Months) MVC-COV1901(6 Months) Taoyuan General Hospital marketed Protein subunit vaccine SARS-CoV-2 spike protein (S-2P)
Flu Vaccine Flu Vaccine La Fundacion Favaloro para la Investigacion y la Docencia Medica marketed Prophylactic vaccine Influenza A and B viral hemagglutinin and neuraminidase surface antigens
BNT162b6 Bivalent (Original/OMI BA.4/BA.5) bnt162b6-bivalent-original-omi-ba-4-ba-5 Pfizer marketed vaccine SARS-CoV-2 spike protein

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (vaccine class)

  1. Pfizer · 20 drugs in this class
  2. Sanofi Pasteur, a Sanofi Company · 20 drugs in this class
  3. GlaxoSmithKline · 12 drugs in this class
  4. Merck Sharp & Dohme LLC · 12 drugs in this class
  5. Centers for Disease Control and Prevention · 9 drugs in this class
  6. Zhejiang Provincial Center for Disease Control and Prevention · 7 drugs in this class
  7. Jiangsu Province Centers for Disease Control and Prevention · 6 drugs in this class
  8. Beijing Center for Disease Control and Prevention · 6 drugs in this class
  9. International Centre for Diarrhoeal Disease Research, Bangladesh · 5 drugs in this class
  10. Sinovac Biotech Co., Ltd · 4 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vaccine manufactured at commercialized scale — Competitive Intelligence Brief. https://druglandscape.com/ci/vaccine-manufactured-at-commercialized-scale. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: